was isolated from the plasma of a patient with mild hemophilia B. The patient's plasma contained 5% Factor IX clotting activity but 100 % Factor IX antigenic activity as determined by immunological assays, which included inhibitor neutralization and a radioimmuno-assay for Factor IX. This abnormal Factor IX is called Factor IX Chapel Hill (Factor IXcH). Both normal Factor IX and Factor IXCH have tyrosine as the NH2-terminal amino acid. The two proteins have a similar molecular weight, a similar amino acid analysis, the same number of gamma-carboxyglutamic acid residues (10 y-carboxyglutamic acid residues), and a similar carbohydrate content. Both exist as a single-chain glycoprotein in plasma. The major difference between normal Factor...
Factor XI (FXI) is the zymogen precursor of an active serine protease that participates in the conta...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
A method for specific removal of large amounts of factor lX:C alloantibodies by a resin to which hig...
abnormal Factor IX molecule isolated from the plasma of a patient with mild hemophilia B, has previo...
We have characterized at the DNA and protein levels a mutant factor IX, factor IX Strasbourg 2, whic...
Two structurally different forms of activated human Factor IX (Factor IXa alpha and IXa beta) have b...
This report describes the analysis of a novel mutant human factor IX protein from a patient with hem...
Factor lX,,,,,. is a variant factor IX molecule responsible for a clinically moderate form of hemoph...
A murine hybridoma clone is described that grows continuously in culture and produces a monoclonal a...
We used recombinant DNA techniques to map a panel of six monoclonal antibodies (MoAbs) to regions of...
Hemophilia BVancouver, is a moderately severe hereditary disorder in which the factor IX antigen is ...
is characterized by low levels of factor IX antigen and activity before the age of 1 5. whereas afte...
DNA sequence analysis of the Factor IX gene from a hemophilia B patient (98% Factor IX antigen; less...
Hemophilia is a sex linked, recessive, hereditary disorder characterizedby excessive bleeding. This ...
Factor IX antigen (IX:Ag) was measured with three different immunoradiometric assays (IRMAs) in 30 h...
Factor XI (FXI) is the zymogen precursor of an active serine protease that participates in the conta...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
A method for specific removal of large amounts of factor lX:C alloantibodies by a resin to which hig...
abnormal Factor IX molecule isolated from the plasma of a patient with mild hemophilia B, has previo...
We have characterized at the DNA and protein levels a mutant factor IX, factor IX Strasbourg 2, whic...
Two structurally different forms of activated human Factor IX (Factor IXa alpha and IXa beta) have b...
This report describes the analysis of a novel mutant human factor IX protein from a patient with hem...
Factor lX,,,,,. is a variant factor IX molecule responsible for a clinically moderate form of hemoph...
A murine hybridoma clone is described that grows continuously in culture and produces a monoclonal a...
We used recombinant DNA techniques to map a panel of six monoclonal antibodies (MoAbs) to regions of...
Hemophilia BVancouver, is a moderately severe hereditary disorder in which the factor IX antigen is ...
is characterized by low levels of factor IX antigen and activity before the age of 1 5. whereas afte...
DNA sequence analysis of the Factor IX gene from a hemophilia B patient (98% Factor IX antigen; less...
Hemophilia is a sex linked, recessive, hereditary disorder characterizedby excessive bleeding. This ...
Factor IX antigen (IX:Ag) was measured with three different immunoradiometric assays (IRMAs) in 30 h...
Factor XI (FXI) is the zymogen precursor of an active serine protease that participates in the conta...
The activation of Factor IX by partially purified Factor XIa was followed by active site titration, ...
A method for specific removal of large amounts of factor lX:C alloantibodies by a resin to which hig...